• Ketaki Sharma, Clayton Chiu, and Nicholas Wood.
• National Centre for Immunisation Research and Surveillance for Vaccine Preventable Diseases, The Children's Hospital at Westmead, Sydney.
• Aust Prescr. 2019 Aug 1; 42 (4): 131-135.

Invasive Meningococcal Disease Is A Rare But Serious Infection Caused By Neisseria MeningitidisSerogroup B Was The Predominant Serogroup Causing Invasive Meningococcal Disease In Australia Until 2015 Serogroup W Disease Has Increased Substantially Since 2014 And In 2017 Serogroups B And W Caused Similar Numbers Of Invasive Disease CasesVaccines Against Serogroups A C W Y And B Are Available For Anyone Who Wishes To Reduce The Risk Of Meningococcal DiseaseVaccination Is Strongly Recommended For People In High Risk Age Or Population Groups These Are Children Under 2 Years 15–19 Year Olds Aboriginal And Torres Strait Islander Children And People With Medical Occupational Behavioural Or Travel Related Risk Factors For Invasive Meningococcal DiseaseMeningococcal Acwy Vaccine Is Funded Under The National Immunisation Program For Babies Aged 12 Months Since April 2019 It Has Been Funded For Year 10 Students Through A School Program There Are Additional State And Territory Based Programs For Both Meningococcal Acwy And Meningococcal B Vaccines

3 keywords...

hide…